On Thursday, April 16, the White House released guidance for a phased-in approach for easing social distancing and stay-at-home restrictions instituted in response to the novel coronavirus-19. In a call with state governors on Thursday, President Trump said that each state can determine its own plan for reopening, and that the White House three-phase plan titled, "Guidelines: Opening Up America Again," was intended to serve as general guidance and was not a mandate.
Some state governors are starting to lay out forward-looking scenarios. However, state governors remain concerned about relaxing stay-at-home restrictions too early, before there is the capacity to clearly identify who is sick and where.
Posted 4/17/2020

In an effort to improve outcomes and deliver the highest quality of care to patients with pancreatic cancer, Duke Cancer Institute launched a multidisciplinary Pancreatic Cancer Center that prioritizes thorough surveillance of high-risk patients, stays at the forefront of clinical trials, and considers the role of comorbidities.

Electronic patient-reported outcomes (ePROs) can address limited visibility into patients' health and well-being between visits. Yet, many solutions remain generic in their workflows and mainly help capture adverse events, without helping care teams proactively manage or prevent them from worsening. Cureety offers a new kind of ePRO solution, specialized in oncology and designed to make care better quality, more efficient, and more proactive for all patients.

In the latest episode of Oncology Unscripted, hosts Deirdre Saulet and Mark Liu sit down with Andrew Ambort, DO, a palliative care consulting physician whose work in reshaping the role of palliative care across oncology helped WellSpan Health win a 2025 ACCC Innovator Award.

Patients with rare diseases and their families often feel isolated and overlooked, with many medical questions left unanswered and few people who can empathize with their condition. Rare Disease Day is observed globally each year to bring awareness for diseases and the people behind them by promoting the challenges these rare medical journeys pose for patients and caregivers.
